Vijay P. Sankaran
On July 12, 2024, the Board of Directors (the “Board”) of Veralto Corporation (the “Company”) appointed Vijay P. Sankaran as a Class I member of the Board, effective July 12, 2024.
Highest-materiality recent filing
Veralto issues $725M of 4.850% Senior Notes due 2032, net proceeds ~$718.8M
$725M aggregate principal at 4.850%, maturing Jan 15, 2032.
Veralto shareholders elect four Class III directors, ratify auditor, approve say-on-pay
All four Class III nominees (Honeycutt, Filler, Mitts, Williams) elected with >208M votes each.
Veralto Q1 sales up 6.7% to $1.42B; raises FY adjusted EPS guidance to $4.20-4.28
Sales $1,422M (+6.7% YoY); core sales growth 1.9%; adjusted EPS $1.07, up 13% YoY.
Veralto Q4 sales +3.8% to $1,396M; FY2025 EPS $3.76; raises dividend 18%
Q4 sales $1,396M (+3.8% YoY); core sales +1.6%; net earnings $254M ($1.01 diluted EPS); adjusted EPS $1.04.
Veralto announces $750M share repurchase program with no expiration date
Board approved up to $750M of common stock repurchases on November 25, 2025.
Veralto appoints Kimberly Chainey as SVP and Chief Legal Officer effective Dec 1, 2025
Kimberly Chainey named SVP & Chief Legal Officer effective Dec 1, 2025; reports to CEO Jennifer Honeycutt.
Veralto Q3 sales up 6.9% to $1.4B; raises full-year adjusted EPS guidance to $3.82-$3.85
Sales $1,404M (+6.9% YoY); core sales growth 5.1%.
Veralto CLO Sylvia Stein to depart Oct 31; severance of $592,250 plus continued equity vesting
Sylvia Stein, SVP & Chief Legal Officer, steps down Oct 31, 2025; remains in transition role until Jan 2, 2026.
Veralto Q2 sales up 6.4% to $1.37B, raises FY2025 EPS and core sales guidance
Sales of $1,371M (+6.4% YoY); non-GAAP core sales growth 4.8%.
Veralto shareholders approve board declassification and removal of supermajority voting requirements
Board declassification approved; annual director elections will begin 2026.
Veralto Q1 sales up 6.9% to $1.33B, adjusted EPS $0.95; reaffirms FY2025 guidance
Sales $1,332M (+6.9% YoY); core sales growth 7.8%; adjusted operating margin 25.0%.
Veralto Q4 sales $1,345M (+4.4%), adjusted EPS $0.95; FY25 guided $3.60-$3.70
Q4 sales $1,345M (+4.4% YoY); adjusted EPS $0.95; operating cash flow $285M.
Veralto Q3 sales up 4.7% to $1.314B, raises FY EPS guidance to $3.44-$3.48
Sales $1,314M (+4.7% YoY); core sales growth 4.6% non-GAAP; diluted EPS $0.88 GAAP, $0.89 adjusted.
Veralto Q2 sales $1.29B (+2.8% YoY), raises FY adjusted EPS guidance to $3.37-$3.45
Net earnings $203M ($0.81 diluted EPS), adjusted EPS $0.85; both beat prior expectations.
Veralto appoints Vijay Sankaran to board of directors, Audit Committee
Vijay P. Sankaran appointed as Class I director effective July 12, 2024.
Veralto shareholders elect three Class I directors, approve say-on-pay at annual meeting
Directors Françoise Colpron, Shyam P. Kambeyanda, William H. King elected to three-year terms with >92% of votes cast.
Veralto Q1 2024: Revenue $1.246B, adj. EPS $0.84; raises FY adj. EPS guidance
Sales up 1.8% YoY to $1,246M; core sales growth also 1.8%.
On July 12, 2024, the Board of Directors (the “Board”) of Veralto Corporation (the “Company”) appointed Vijay P. Sankaran as a Class I member of the Board, effective July 12, 2024.
Max materiality 0.80 · Median 0.70 · Most common event earnings